RecruitingNot ApplicableNCT05439226

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease


Sponsor

State Key Laboratory of Subhealth Intervention Technology

Enrollment

120 participants

Start Date

Jul 5, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Type 2 diabetes (T2D) represents a serious public health problem. Patients with T2D and non-alcoholic fatty liver disease(NAFLD) demonstrate a poor metabolic profile and increase mortality compared with patients with only NAFLD or T2D. Nutritional intervention is the most basic treatment for T2D. Previous study showed that a Chinese medical nutrition therapy (CMNT) diet, which intermittent use of low-calorie medicinal food, has a glucose-lowering effect in T2D. This study aims to investigate the effect of a Chinese medical nutrition therapy (CMNT) diet accompanied by intermittent energy restriction on reducing liver fat and glycated hemoglobin (HbA1c) in patients with T2D and NAFLD.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria6

  • Patients diagnosed with type 2 diabetes and NAFLD
  • Age between 18 and 75 years
  • BMI between 18.0 and 35.0 kg/m2
  • Weight stable for at least 3 months prior to the study (gain or loss \< 4 kg)
  • Stable treatment for at least 3 months with 1-3 oral antidiabetic medications (with or without insulin therapy), or not yet received antidiabetic medication prior to the beginning of the study
  • Able to give written informed consent

Exclusion Criteria11

  • Self-reported a food allergy
  • Alcohol abuse in the last 3 months (alcohol intake greater than 20 g per day for women; Alcohol intake for men greater than 40 g per day)
  • Other liver diseases such as chronic hepatitis B and C, autoimmune hepatitis, primary biliary cirrhosis, hemochromatosis, nodular regenerative hyperplasia and focal nodular hyperplasia
  • Scheduled to be hospitalized for any surgical treatment during screening
  • Pregnant or planning of pregnancy during the study
  • Inability, physically or mentally, to adhere the procedures required by the study protocol
  • Level 3 hypoglycemic events (at least 3 times) occurring within the 90 days prior to screening
  • Hospitalization or emergency department visit for hyperglycemia, diabetic ketoacidosis, lactic acidosis, hyperosmolar nonketotic coma, or diabetes
  • History of cancer within the past 5 years
  • Acute coronary or cerebrovascular event in the past 90 days, or heart failure
  • Hemorrhagic or ischemic stroke within the last 6 months

Interventions

OTHERCMNT diet

Hypocaloric CMNT diet plan: A diet plan with intermittent use of enriched traditional-Chinese-medicinal-foods CMNT diet


Locations(3)

Physical Examination Center of Gezhouba central hospital of Sinopharm

Yichang, Hubei, China

Hunan Shanshui physical examination center

Changsha, Hunan, China

Jinheyuan Outpatient Department, National Sub-health Intervention Technology Achievement Application Center

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05439226


Related Trials